Cite
HARVARD Citation
Rigolin, G. et al. (2021). Efficacy of idelalisib and rituximab in relapsed/refractory chronic lymphocytic leukemia treated outside of clinical trials. A report of the Gimema Working Group. Hematological oncology. 39 (3), pp. 326-335. [Online].